These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36646315)

  • 1. COPE and oxytocin for the treatment of co-occurring PTSD and alcohol use disorder: Design and methodology of a randomized controlled trial in U.S. military veterans.
    Back SE; Flanagan JC; Killeen T; Saraiya TC; Brown DG; Jarnecke AM; Rothbaum AO; Joseph J; Ana ES; de Arellano A; Shoemaker HL; Dixon RA; Nietert PJ; Brady KT
    Contemp Clin Trials; 2023 Mar; 126():107084. PubMed ID: 36646315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxazosin for the treatment of co-occurring PTSD and alcohol use disorder: Design and methodology of a randomized controlled trial in military veterans.
    Back SE; Flanagan JC; Jones JL; Augur I; Peterson AL; Young-McCaughan S; Shirley DW; Henschel A; Joseph JE; Litz BT; Hancock AK; Roache JD; Mintz J; Wachen JS; Keane TM; Brady KT;
    Contemp Clin Trials; 2018 Oct; 73():8-15. PubMed ID: 30145268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-acetylcysteine for the treatment of comorbid alcohol use disorder and posttraumatic stress disorder: Design and methodology of a randomized clinical trial.
    Back SE; Gray K; Santa Ana E; Jones JL; Jarnecke AM; Joseph JE; Prisciandaro J; Killeen T; Brown DG; Taimina L; Compean E; Malcolm R; Flanagan JC; Kalivas PW
    Contemp Clin Trials; 2020 Apr; 91():105961. PubMed ID: 32087337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of oxytocin on stress reactivity and craving in veterans with co-occurring PTSD and alcohol use disorder.
    Flanagan JC; Allan NP; Calhoun CD; Badour CL; Moran-Santa Maria M; Brady KT; Back SE
    Exp Clin Psychopharmacol; 2019 Feb; 27(1):45-54. PubMed ID: 30382728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of oxytocin administration on fear-potentiated acoustic startle in co-occurring PTSD and alcohol use disorder: A randomized clinical trial.
    Stauffer CS; Morrison TE; Meinzer NK; Leung D; Buffington J; Sheh EG; Neylan TC; O'Donovan A; Woolley JD
    Psychiatry Res; 2022 Feb; 308():114340. PubMed ID: 34983010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Craving Moderates the Effects of Intranasal Oxytocin on Anger in Response to Social Stress Among Veterans With Co-Occurring Posttraumatic Stress Disorder and Alcohol Use Disorder.
    Melkonian AJ; Flanagan JC; Calhoun CD; Hogan JN; Back SE
    J Clin Psychopharmacol; 2021 Jul-Aug 01; 41(4):465-469. PubMed ID: 34121063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Oxytocin Administration on Cue-Induced Craving in Co-occurring Alcohol Use Disorder and PTSD: A Within-Participant Randomized Clinical Trial.
    Stauffer CS; Meinzer NK; Morrison T; Wen JH; Radanovich L; Leung D; Niles A; O'Donovan A; Batki SL; Woolley JD
    Alcohol Clin Exp Res; 2019 Dec; 43(12):2627-2636. PubMed ID: 31610033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automatic Imitation in Comorbid PTSD & Alcohol Use Disorder and Controls: an RCT of Intranasal Oxytocin.
    Morrison TE; De Coster L; Stauffer CS; Wen J; Ahmadi E; Delucchi K; O'Donovan A; Woolley J
    Psychoneuroendocrinology; 2020 Oct; 120():104787. PubMed ID: 32745891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Alcohol Use, Traumatic Stress, and Cigarette Smoking on Cognitive Functioning in Veterans With Co-occurring Alcohol Use Disorder and Posttraumatic Stress Disorder.
    Hua JPY; Cano M; Batki SL; Pennington DL
    Mil Med; 2023 Jul; 188(7-8):e2208-e2216. PubMed ID: 36179109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Double-Blind Randomized Controlled Trial of Doxazosin for Co-Occurring PTSD and Alcohol Use Disorder in Veterans.
    Back SE; Flanagan JC; Mintz J; Brady KT; Jones J; Jarnecke AM; Joseph JE; Shirley DW; Malcolm RJ; Hamner M; Litz BT; Niles BL; Young-McCaughan S; Keane TM; Peterson AL
    J Clin Psychiatry; 2023 Mar; 84(2):. PubMed ID: 36883885
    [No Abstract]   [Full Text] [Related]  

  • 11. Alcohol-related and mental health care for patients with unhealthy alcohol use and posttraumatic stress disorder in a National Veterans Affairs cohort.
    Chen JA; Owens MD; Browne KC; Williams EC
    J Subst Abuse Treat; 2018 Feb; 85():1-9. PubMed ID: 29291765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Integrated Exposure Therapy vs Integrated Coping Skills Therapy for Comorbid Posttraumatic Stress Disorder and Alcohol Use Disorder: A Randomized Clinical Trial.
    Norman SB; Trim R; Haller M; Davis BC; Myers US; Colvonen PJ; Blanes E; Lyons R; Siegel EY; Angkaw AC; Norman GJ; Mayes T
    JAMA Psychiatry; 2019 Aug; 76(8):791-799. PubMed ID: 31017639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alcohol Abstainer Status and Prazosin Treatment in Association with Changes in Posttraumatic Stress Disorder Symptoms in Veterans with Comorbid Alcohol Use Disorder and Posttraumatic Stress Disorder.
    Verplaetse TL; Ralevski E; Roberts W; Gueorguieva R; McKee SA; Petrakis IL
    Alcohol Clin Exp Res; 2019 Apr; 43(4):741-746. PubMed ID: 30698839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy for Co-Occurring Alcohol Use Disorder and Post-Traumatic Stress Disorder: Targeting the Opioidergic, Noradrenergic, Serotonergic, and GABAergic/Glutamatergic Systems.
    Verplaetse TL; McKee SA; Petrakis IL
    Alcohol Res; 2018; 39(2):193-205. PubMed ID: 31198658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing prolonged exposure therapy for PTSD among veterans with oxytocin: Design of a multisite randomized controlled trial.
    Flanagan JC; Mitchell JM; Baker NL; Woolley J; Wangelin B; Back SE; McQuaid JR; Neylan TC; Wolfe WR; Brady KT
    Contemp Clin Trials; 2020 Aug; 95():106074. PubMed ID: 32561468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The burden of co-occurring alcohol use disorder and PTSD in U.S. Military veterans: Comorbidities, functioning, and suicidality.
    Norman SB; Haller M; Hamblen JL; Southwick SM; Pietrzak RH
    Psychol Addict Behav; 2018 Mar; 32(2):224-229. PubMed ID: 29553778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosocial functioning in integrated treatment of co-occurring posttraumatic stress disorder and alcohol use disorder.
    Lyons R; Panza KE; Helm J; Angkaw AC; Straus E; Norman SB
    J Psychiatr Res; 2021 Oct; 142():40-47. PubMed ID: 34314993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral activation for veterans with co-occurring alcohol use disorder and posttraumatic stress disorder: Basis and methodology for a pilot randomized controlled trial.
    Blakey SM; Alsobrooks AK; Morgan-López AA; Kruskamp N; Simpson TL; Daughters SB; DuBois CM; Huang JS; Evans J; Serrano BN; Calhoun PS; Beckham JC; Elbogen EB
    Contemp Clin Trials; 2024 Nov; 146():107670. PubMed ID: 39186971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing psychosocial functioning, suicide risk, and nonsuicidal self-injury between veterans with probable posttraumatic stress disorder and alcohol use disorder.
    Blakey SM; Griffin SC; Grove JL; Peter SC; Levi RD; Calhoun PS; Elbogen EB; Beckham JC; Pugh MJ; Kimbrel NA
    J Affect Disord; 2022 Jul; 308():10-18. PubMed ID: 35398395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbid alcohol use and post-traumatic stress disorders: Pharmacotherapy with aldehyde dehydrogenase 2 inhibitors versus current agents.
    Morice CK; Yammine L; Yoon J; Lane SD; Schmitz JM; Kosten TR; De La Garza R; Verrico CD
    Prog Neuropsychopharmacol Biol Psychiatry; 2022 Apr; 115():110506. PubMed ID: 34995723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.